Many benign conditions, such as endometriosis, uterine fibroids, or even severe menstrual cramping, can also raise these levels. Multiplex Assays and Emerging Biomarkers The field of oncology is rapidly evolving, and ovarian cancer lab tests are no exception.
Ovarian Cancer Postmenopausal Testing: Understanding CA-125 and HE4 Lab Results
The Cornerstone Test: CA-125 Blood Assay The most recognized ovarian cancer lab test is the CA-125 blood assay. If a CA-125 level is rising over time in a patient being monitored for potential ovarian issues, it can be a powerful indicator that warrants further investigation through imaging or surgical consultation.
These advancements aim to catch the disease earlier and provide a clearer picture of the cancer's aggressiveness. Interpreting Results in Context Because of the limitations of CA-125, healthcare providers look at the result within a broader clinical context.
Ovarian Cancer Postmenopausal Testing: Understanding CA-125 and HE4 Blood Assays
This score is particularly useful for women experiencing pelvic pain or bloating, helping to stratify their risk into low, moderate, or high categories. HE4 is a protein that is often elevated in ovarian cancer but is less likely to be raised by benign conditions.
More About Ovarian cancer lab tests
Looking at Ovarian cancer lab tests from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Ovarian cancer lab tests can make the topic easier to follow by connecting earlier points with a few simple takeaways.
